PROSTAGLANDIN-E1 - A NEW THERAPY FOR REFRACTORY RIGHT HEART-FAILURE AND PULMONARY-HYPERTENSION AFTER MITRAL-VALVE REPLACEMENT

被引:0
|
作者
DAMBRA, MN
LARAIA, PJ
PHILBIN, DM
WATKINS, WD
HILGENBERG, AD
BUCKLEY, MJ
机构
[1] MASSACHUSETTS GEN HOSP,DEPT SURG,SURG CARDIOVASC UNIT,BOSTON,MA 02114
[2] MASSACHUSETTS GEN HOSP,DEPT MED,CARDIAC UNIT,BOSTON,MA 02114
[3] HARVARD UNIV,SCH MED,DEPT ANAESTHESIA,BOSTON,MA 02115
[4] HARVARD UNIV,SCH MED,DEPT SURG,BOSTON,MA 02115
[5] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:567 / 572
页数:6
相关论文
共 50 条
  • [21] LONG-TERM RESULTS OF MITRAL-VALVE REPLACEMENT IN PATIENTS WITH SEVERE PULMONARY-HYPERTENSION
    JEGADEN, O
    ROSSI, R
    DELAHAYE, F
    MONTAGNA, P
    DELAYE, J
    DELAHAYE, JP
    MIKAELOFF, P
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1991, 84 (09): : 1297 - 1301
  • [22] TAKAYASUS DISEASE-CAUSING PULMONARY-HYPERTENSION AND RIGHT HEART-FAILURE
    CAVERO, MA
    MAICAS, C
    SILVA, L
    ORTIGOSA, J
    YEBRA, M
    CAMACHO, C
    DEARTAZA, M
    AMERICAN HEART JOURNAL, 1994, 127 (02) : 450 - 451
  • [23] THE EFFECT OF LOW-DOSE INTRAVENOUS NITROGLYCERIN ON PULMONARY-HYPERTENSION IMMEDIATELY AFTER REPLACEMENT OF A STENOTIC MITRAL-VALVE
    ZISKIND, Z
    POHORYLES, L
    MOHR, R
    SMOLINSKY, A
    QUANG, HT
    RUVOLO, G
    GOOR, DA
    CIRCULATION, 1985, 72 (03) : 164 - 169
  • [24] HEMODYNAMIC-EFFECTS OF PROSTAGLANDIN-E1 IN PATIENTS WITH CONGENITAL HEART-DISEASE AND PULMONARY-HYPERTENSION
    WEESNER, KM
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1991, 24 (01): : 10 - 15
  • [25] PROSTAGLANDIN-E1 AND INTRAPULMONARY SHUNT IN CARDIAC SURGICAL PATIENTS WITH PULMONARY-HYPERTENSION
    HEERDT, PM
    WEISS, CI
    ANNALS OF THORACIC SURGERY, 1990, 49 (03) : 463 - 465
  • [26] THE USE OF PROSTAGLANDIN-E1 (PGE1) AS A TEST DRUG IN PULMONARY-HYPERTENSION
    LAMBERT, RJ
    CORRIGAN, PE
    CALDWELL, EJ
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 133 (04): : A402 - A402
  • [27] EFFECTS OF PROSTAGLANDIN-E1 AND OTHER VASODILATOR AGENTS IN PULMONARY-HYPERTENSION OF SCLERODERMA
    BARON, M
    SKRINSKAS, G
    HYLAND, R
    UROWITZ, MB
    BRITISH HEART JOURNAL, 1982, 48 (03): : 304 - 305
  • [28] PULMONARY-HYPERTENSION AND RIGHT HEART-FAILURE IN PATIENTS WITH BETA-THALASSEMIA-INTERMEDIA
    AESSOPOS, A
    STAMATELOS, G
    SKOUMAS, V
    VASSILOPOULOS, G
    MANTZOURANI, M
    LOUKOPOULOS, D
    CHEST, 1995, 107 (01) : 50 - 53
  • [29] EFFECTS OF PROSTAGLANDIN-E1 ON PULMONARY CIRCULATION AND BLOOD-GAS IN PATIENTS WITH PULMONARY-HYPERTENSION
    MIYATAKE, H
    KADO, T
    KAN, Z
    FUJITANI, K
    FUKUZAKI, H
    MATSUDA, Y
    FUJIWARA, K
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1981, 45 (08): : 889 - 889
  • [30] REDUCTION IN PULMONARY-HYPERTENSION BY PROSTAGLANDIN-E1 IN DECOMPENSATED CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    NAEIJE, R
    MELOT, C
    MOLS, P
    HALLEMANS, R
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1982, 125 (01): : 1 - 5